Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas.

[1]  M. Lippman,et al.  Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. , 1993, Journal of the National Cancer Institute.

[2]  T. Shimosegawa,et al.  The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasma of the pancreas , 1993, International journal of pancreatology : official journal of the International Association of Pancreatology.

[3]  T. Hurskainen,et al.  Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[4]  H. Sasano,et al.  An immunohistochemical study of the c‐erbB‐2 oncogene product in intraductal mucin‐hypersecreting neoplasms and in ductal cell carcinomas of the pancreas , 1993, Cancer.

[5]  Y. Soini,et al.  Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. , 1993, The American journal of pathology.

[6]  W. Stetler-Stevenson,et al.  Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1993, Biochemistry.

[7]  L. Liotta,et al.  Molecular aspects of tumor cell invasion and metastasis , 1993, Cancer.

[8]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[9]  W. Stetler-Stevenson,et al.  Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. , 1993, Kidney international.

[10]  L. Liotta,et al.  Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  A. Ooshima,et al.  Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  R Poulsom,et al.  Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. , 1992, The American journal of pathology.

[13]  L. Liotta,et al.  Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the Ovary , 1992, The American journal of surgical pathology.

[14]  M. Cockett,et al.  The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.

[15]  T. Hurskainen,et al.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.

[16]  C. Stewart,et al.  Distribution of type IV collagen immunoreactivity to assess questionable early stromal invasion. , 1992, Journal of clinical pathology.

[17]  D. Powe,et al.  Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours , 1991, International journal of cancer.

[18]  J. Devière,et al.  Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients. , 1991, Gastroenterology.

[19]  D. Powe,et al.  Relationships between epithelial basement membrane staining patterns in primary colorectal carcinomas and the extent of tumour spread , 1991, International journal of cancer.

[20]  K. Yamao,et al.  Mucin‐producing tumor of the pancreas , 1991, Cancer.

[21]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[22]  L. Liotta,et al.  Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. , 1991, Cancer research.

[23]  P. Chambon,et al.  A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas , 1990, Nature.

[24]  L. Liotta,et al.  Extraction of type‐IV collagenase/gelatinase from plasma membranes of human cancer cells , 1990, International journal of cancer.

[25]  L. Liotta,et al.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. , 1990, The American journal of pathology.

[26]  L. Liotta,et al.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.

[27]  G. Klöppel,et al.  Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients , 1989, Cancer.

[28]  K. Tryggvason,et al.  Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. , 1989, The Biochemical journal.

[29]  L. Liotta,et al.  The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. , 1989, The Journal of biological chemistry.

[30]  B. Pauli,et al.  Tumor invasion: a consequence of destructive and compositional matrix alterations. , 1988, Human pathology.

[31]  Y. Atomi,et al.  Mucin-hypersecreting carcinoma of the pancreas. , 1987, Radiology.

[32]  G. Nicolson,et al.  Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. , 1987, Cancer research.

[33]  H. Kern,et al.  Distribution of Extracellular Matrix Proteins in Pancreatic Ductal Adenocarcinoma and Its Influence on Tumor Cell Proliferation in Vitro , 1987, Pancreas.

[34]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[35]  S. Nordling,et al.  Expression of laminin in pancreatic neoplasms and in chronic pancreatitis , 1984, The American journal of surgical pathology.

[36]  K. Tryggvason,et al.  Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. , 1984, The Journal of biological chemistry.

[37]  G P Siegal,et al.  Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[38]  P. Amenta,et al.  The basement membrane in pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[39]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[40]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[41]  H. Furthmayr,et al.  Isolation and tissue localization of type AB2 collagen from normal lung parenchyma. , 1979, The American journal of pathology.

[42]  J. Oertel,et al.  Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. , 1978, American journal of clinical pathology.

[43]  R. Vracko,et al.  Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. , 1974, The American journal of pathology.